RecallClass 4 · Caution in use
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Read and act on the official notice on GOV.UK
Class 4 recall — Caution in use.
The MHRA uses Class 4 when:
Usually minor defects in packaging or other printed materials.
What all four recall classes mean
| Class | Action | The MHRA's definition |
|---|---|---|
| Class 1 | Immediate action | The defect presents a risk of death or disability. |
| Class 2 | Action within 48 hours | The defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious. |
| Class 3 | Action within 5 days | The defect is unlikely to cause harm to the patient. |
| Class 4 this recall | Caution in use | Usually minor defects in packaging or other printed materials. |
A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.
The MHRA's summary
Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.
Affected batches
As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.
| Batch number | Expiry | Pack size | First distributed |
|---|---|---|---|
| Xaggitin XL 18 mg Prolonged-release Tablets | |||
| 183155 | 30/10/2027 | 30 tablets | 17/03/2026 |
| 185442 | 31/12/2027 | 30 tablets | Not yet distributed |
| Xaggitin XL 27 mg Prolonged-release Tablets | |||
| 174975 | 31/05/2027 | 30 tablets | 18/02/2026 |
| 175037 | 31/05/2027 | 30 tablets | 21/05/2026 |
| 178223 | 31/07/2027 | 30 tablets | 17/04/2026 |
| 183931 | 30/11/2027 | 30 tablets | Not yet distributed |
| 185438 | 30/11/2027 | 30 tablets | Not yet distributed |
| 185439 | 30/11/2027 | 30 tablets | Not yet distributed |
| 185440 | 30/11/2027 | 30 tablets | 07/04/2026 |
| 187560 | 28/02/2028 | 30 tablets | Not yet distributed |
| Xaggitin XL 36 mg Prolonged-release Tablets | |||
| 175426 | 30/06/2027 | 30 tablets | 12/03/2026 |
| 175428 | 30/06/2027 | 30 tablets | 18/05/2026 |
| 176698 | 30/06/2027 | 30 tablets | 17/03/2026 |
| 176699 | 30/06/2027 | 30 tablets | Not yet distributed |
| 176700 | 30/06/2027 | 30 tablets | Not yet distributed |
| 182875 | 30/09/2027 | 30 tablets | 06/05/2026 |
| 183003 | 31/10/2027 | 30 tablets | Not yet distributed |
| Xaggitin XL 54 mg Prolonged-release Tablets | |||
| 178338 | 31/07/2027 | 30 tablets | 09/02/2026 |
| 178432 | 31/07/2027 | 30 tablets | 31/03/2026 |
| 178481 | 31/07/2027 | 30 tablets | 18/05/2026 |
| 180343 | 30/09/2027 | 30 tablets | 08/06/2026 |
| 187926 | 28/02/2028 | 30 tablets | 03/07/2026 |
| 187927 | 28/02/2028 | 30 tablets | Not yet distributed |
| 187928 | 28/02/2028 | 30 tablets | Not yet distributed |
| 187929 | 28/02/2028 | 30 tablets | Not yet distributed |
| 187930 | 28/02/2028 | 30 tablets | Not yet distributed |
MHRA's audience tags: Dispensing GP practices, Pharmacy